Oleksii S. Rukhlenko
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Polycomb Repressive Complex 2 drives flow-sensitive endothelial states underlying vascular inflammation and disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 31, 2026
IFN γ and IFN γ mimetics prevent IFN-I-mediated TB susceptibility by regulating iron metabolism and lipid peroxidation.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026
Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer.
Journal: Journal of immunotherapy and precision oncology
Published: August 11, 2025
Dual RAF inhibition outperforms RAF-MEK combinations for suppressing ERK signaling in KRAS mutant cells.
Journal: NPJ systems biology and applications
Published: July 29, 2025
A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
cSTAR analysis identifies endothelial cell cycle as a key regulator of flow-dependent artery remodeling.
Journal: Science advances
Published: January 03, 2025
Lipid Peroxidation and Type I Interferon Coupling Fuels Pathogenic Macrophage Activation Causing Tuberculosis Susceptibility.
Journal: bioRxiv : the preprint server for biology
Published: March 18, 2024
VEGF counteracts shear stress-determined arterial fate specification during capillary remodeling.
Journal: bioRxiv : the preprint server for biology
Published: February 08, 2024
Cell-specific models reveal conformation-specific RAF inhibitor combinations that synergistically inhibit ERK signaling in pancreatic cancer cells.
Journal: Cell reports
Published: December 19, 2023
Last Updated: 09/26/2026